Ergomed
Roy Ovel brings more than 30 years of experience in international business development with a number of the global CROs to his new role as chief commercial officer at Ergomed.
Ovel has held positions at Icon, TFS, and Worldwide Clinical Trials, as well as with smaller, specialist CROs.
In his new role he joins Ergomed’s executive team and will be responsible for global sales and business development activities across the company’s full services offering.
